Sri Lanka: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)   |   CE2022-0018

Contact:

Office of Agricultural Affairs, Colombo   |   (011-94) (11) 249-8500

Sri Lanka does not produce genetically engineered (GE) crops or animals. There is some GE research at the laboratory level, but there is no commercialization. The lack of a legal framework and biosafety procedures are a major setback; the country is in the process of finalizing regulatory biotechnology policies. Policies remain at varying stages of development and implementation, and include the National Biotechnology Policy, the National Biosafety Framework (that encompasses the National Biosafety Policy and National Biosafety Act), as well as the Control of Import, Labeling and Sale of Genetically Modified Foods Regulation of 2006. Development of the National Biosafety Framework conforms to commitments made under the Cartagena Protocol (signed in 2000 and ratified in 2004). The new legal framework for biosafety will become effective with the enactment of the National Biosafety Act. The draft act is with the Legal Draftsman's Department, awaiting further approvals from the Attorney General and the Cabinet.

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.